211 related articles for article (PubMed ID: 31258218)
1. Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis.
Hu YJ; Ogyu A; Cowling BJ; Fukuda K; Pang HH
Bull World Health Organ; 2019 Jul; 97(7):486-501B. PubMed ID: 31258218
[TBL] [Abstract][Full Text] [Related]
2. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
Detsis M; Karanika S; Mylonakis E
Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
Sfeir MM; Askin G; Christos P
Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis.
Flokas ME; Detsis M; Alevizakos M; Mylonakis E
J Infect; 2016 Dec; 73(6):547-557. PubMed ID: 27475789
[TBL] [Abstract][Full Text] [Related]
5. Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in pregnant/post-partum women: Systematic review and meta-analysis.
Jalilian N; Kooshkiforooshani M; Ahmadi S; Nankali A
J Glob Antimicrob Resist; 2019 Dec; 19():338-347. PubMed ID: 31212106
[TBL] [Abstract][Full Text] [Related]
6. [Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].
Simões A; Lima M; Brett A; Queiroz C; Chaves C; Oliveira H; Januário L; Rodrigues F
Acta Med Port; 2020 Jul; 33(7-8):466-474. PubMed ID: 31962058
[TBL] [Abstract][Full Text] [Related]
7. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
8. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections.
Tacconelli E; Cataldo MA; Mutters NT; Carrara E; Bartoloni A; Raglio A; Cauda R; Mantengoli E; Luzzaro F; Pan A; Beccara LA; Pecile P; Tinelli M; Rossolini GM
Int J Antimicrob Agents; 2019 Jul; 54(1):49-54. PubMed ID: 30986523
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis.
Alevizakos M; Gaitanidis A; Andreatos N; Arunachalam K; Flokas ME; Mylonakis E
Int J Antimicrob Agents; 2017 Nov; 50(5):657-663. PubMed ID: 28705665
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study.
De Angelis G; Restuccia G; Venturiello S; Cauda R; Malhotra-Kumar S; Goossens H; Schrenzel J; Tacconelli E
BMC Infect Dis; 2012 Mar; 12():74. PubMed ID: 22458427
[TBL] [Abstract][Full Text] [Related]
11. Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis.
Karanika S; Karantanos T; Arvanitis M; Grigoras C; Mylonakis E
Clin Infect Dis; 2016 Aug; 63(3):310-8. PubMed ID: 27143671
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
14. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa.
Cotton MF; Wasserman E; Smit J; Whitelaw A; Zar HJ
BMC Infect Dis; 2008 Apr; 8():40. PubMed ID: 18380900
[TBL] [Abstract][Full Text] [Related]
15. Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Prinapori R; Guinaud J; Khalil A; Lecuyer H; Gendrel D; Lortholary O; Nassif X; Viscoli C; Zahar JR
Am J Infect Control; 2013 Mar; 41(3):259-60. PubMed ID: 23062579
[TBL] [Abstract][Full Text] [Related]
16. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis.
Vardakas KZ; Tansarli GS; Rafailidis PI; Falagas ME
J Antimicrob Chemother; 2012 Dec; 67(12):2793-803. PubMed ID: 22915465
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis.
Flokas ME; Alevizakos M; Shehadeh F; Andreatos N; Mylonakis E
Int J Antimicrob Agents; 2017 Nov; 50(5):649-656. PubMed ID: 28782707
[TBL] [Abstract][Full Text] [Related]
19. High carriage rates of extended-spectrum beta-lactamase-producing
Jewoola OO; Bode-Sojobi IO; Ogunsola FT; Okonji PE
Niger Postgrad Med J; 2020; 27(2):136-142. PubMed ID: 32295946
[TBL] [Abstract][Full Text] [Related]
20. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.
Schoevaerdts D; Bogaerts P; Grimmelprez A; de Saint-Hubert M; Delaere B; Jamart J; Swine C; Glupczynski Y
BMC Infect Dis; 2011 Jan; 11():12. PubMed ID: 21226923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
